CN115368431B - 三萜类化合物及其制备方法与用途 - Google Patents
三萜类化合物及其制备方法与用途 Download PDFInfo
- Publication number
- CN115368431B CN115368431B CN202110830985.0A CN202110830985A CN115368431B CN 115368431 B CN115368431 B CN 115368431B CN 202110830985 A CN202110830985 A CN 202110830985A CN 115368431 B CN115368431 B CN 115368431B
- Authority
- CN
- China
- Prior art keywords
- acid
- triterpene compound
- disease
- pharmaceutical composition
- deficit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110830985.0A CN115368431B (zh) | 2021-07-22 | 2021-07-22 | 三萜类化合物及其制备方法与用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110830985.0A CN115368431B (zh) | 2021-07-22 | 2021-07-22 | 三萜类化合物及其制备方法与用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115368431A CN115368431A (zh) | 2022-11-22 |
CN115368431B true CN115368431B (zh) | 2023-08-22 |
Family
ID=84060528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110830985.0A Active CN115368431B (zh) | 2021-07-22 | 2021-07-22 | 三萜类化合物及其制备方法与用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115368431B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105153271A (zh) * | 2015-09-17 | 2015-12-16 | 沈阳农业大学 | 两个新的达玛烷型三萜类化合物及其制备方法和用途 |
CN108774282A (zh) * | 2018-07-23 | 2018-11-09 | 中国科学院兰州化学物理研究所 | 一种绞股蓝中具有抗阿尔茨海默病的达玛烷型三萜皂苷 |
CN112142816A (zh) * | 2019-06-26 | 2020-12-29 | 中央民族大学 | 具有神经保护作用的三萜皂苷类化合物、其制备方法及应用 |
CN113135978A (zh) * | 2021-03-31 | 2021-07-20 | 中国科学院兰州化学物理研究所 | 一种绞股蓝活性成分达玛烷型三萜皂苷及其分离和应用 |
-
2021
- 2021-07-22 CN CN202110830985.0A patent/CN115368431B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105153271A (zh) * | 2015-09-17 | 2015-12-16 | 沈阳农业大学 | 两个新的达玛烷型三萜类化合物及其制备方法和用途 |
CN108774282A (zh) * | 2018-07-23 | 2018-11-09 | 中国科学院兰州化学物理研究所 | 一种绞股蓝中具有抗阿尔茨海默病的达玛烷型三萜皂苷 |
CN112142816A (zh) * | 2019-06-26 | 2020-12-29 | 中央民族大学 | 具有神经保护作用的三萜皂苷类化合物、其制备方法及应用 |
CN113135978A (zh) * | 2021-03-31 | 2021-07-20 | 中国科学院兰州化学物理研究所 | 一种绞股蓝活性成分达玛烷型三萜皂苷及其分离和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN115368431A (zh) | 2022-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11426419B2 (en) | Compositions and methods for the repair of myelin | |
WO2013060258A1 (zh) | 伸筋草碱a-c、其制法和其药物组合物与用途 | |
EP4328224A1 (en) | Parp inhibitor containing piperazine structure, preparation method therefor and pharmaceutical use thereof | |
JP6261677B2 (ja) | スピノシンを含む認知機能障害疾患の予防または治療用薬学組成物 | |
EA023751B1 (ru) | Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности | |
CN104011048B (zh) | 作为磷酸二酯酶抑制剂的[1,2,4]三唑并吡啶类化合物及其应用 | |
CN115368431B (zh) | 三萜类化合物及其制备方法与用途 | |
PT2069334E (pt) | Di-hidrocalcona idêntica a aspalatina, extracto proveniente de rooibos não fermentado e método para a sua preparação | |
CN115368425B (zh) | 三萜类化合物及其制备方法与抗炎用途 | |
CN103183719A (zh) | 皂苷衍生物及其用途 | |
WO2004058244A1 (fr) | Utilisation d'esters de derives succinate pour le traitement de la demence | |
CN113214097B (zh) | 治疗阿尔茨海默病的化合物 | |
EP3165522B1 (en) | Cyclopropyl unsaturated quinoline compound as leukotriene receptor antagonist and use thereof in therapy | |
CN107753469B (zh) | Ndga类似物在制备抗氧化药物中的应用 | |
CN115368426A (zh) | 三萜类化合物及其制备方法与平喘用途 | |
JP7138799B2 (ja) | コリンエステラーゼ阻害剤結晶多形及びその使用 | |
CN109988199B (zh) | 红景天苷衍生物及其用途 | |
CN116217567A (zh) | 烃基取代的α-咔啉类似物或其药用盐、其药物组合物及其制备方法和用途 | |
CN117143027A (zh) | 3-苄氧基-6-羟苯基哒嗪类化合物及其制备方法和用途 | |
KR20150004631A (ko) | 에클랄바사포닌 또는 그 유도체를 포함하는 인지기능 장애 또는 집중력 장애 질환 예방 또는 치료용 약학 조성물 | |
CN114539204A (zh) | 血脑屏障高通透性己糖激酶抑制剂及其合成方法和应用 | |
WO2018232160A1 (en) | Methods of treating metabolic diseases with phenoxyethylamides | |
CN117143074A (zh) | 3-苄氧基-6-吡啶基哒嗪类化合物及其制备方法和用途 | |
JPS63165338A (ja) | ビフエニル誘導体および該誘導体を有効成分とする抗アレルギ−剤 | |
US20140213647A1 (en) | Compound useful for preventing or treating irritable bowel syndrome and composition including same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Tan Daopeng Inventor after: He Yuqi Inventor after: Lu Yanliu Inventor after: Qin Lin Inventor after: Zhang Qianru Inventor after: Lu Anjing Inventor before: He Yuqi Inventor before: Tan Daopeng Inventor before: Lu Yanliu Inventor before: Qin Lin Inventor before: Zhang Qianru Inventor before: Lu Anjing |
|
GR01 | Patent grant | ||
GR01 | Patent grant |